2017
DOI: 10.1111/apt.14189
|View full text |Cite
|
Sign up to set email alerts
|

Letter: role of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus

Abstract: Linked ContentThis article is linked to Hyun and Lee papers. To view these articles visit https://doi.org/10.1111/apt.14068 and https://doi.org/10.1111/apt.14211.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…The above evidence fully demonstrated that 15 mg kg −1 WDNs inhibited PH‐induced RV hypertrophy and improved RV dysfunction. In addition, natural antioxidants such as GSH, [ 41 ] vitamin C, [ 42 ] and clinical drugs for PH treatment fasudil [ 43 ] were conducted for comparison. As shown in Figures S9 and S10, Supporting Information, these control treatments had a negligible therapeutic effect at the samedose as WNDs.…”
Section: Resultsmentioning
confidence: 99%
“…The above evidence fully demonstrated that 15 mg kg −1 WDNs inhibited PH‐induced RV hypertrophy and improved RV dysfunction. In addition, natural antioxidants such as GSH, [ 41 ] vitamin C, [ 42 ] and clinical drugs for PH treatment fasudil [ 43 ] were conducted for comparison. As shown in Figures S9 and S10, Supporting Information, these control treatments had a negligible therapeutic effect at the samedose as WNDs.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, antiviral therapy to prevent vertical transmission of HBV is important to mothers with serum HBeAg-positive status and/or high HBV DNA. 1 In a recent issue of Alimentary Pharmacology & Therapeutics, Wang et al 2 performed an interesting prospective study with single arm to investigate the efficacy and safety of tenofovir disoproxil fumarate to prevent mother-to-child transmission of HBV. In their study, alanine aminotransferase flares were observed in 8.4% of mothers; no infants had birth defects and no serious adverse effects were observed in either mothers or infants.…”
mentioning
confidence: 99%